El síndrome de Dravet es una enfermedad rara. En España solo hay 500 personas que lo sufren, pero se cree que puede haber muchas más, ya que el test genético que lo diagnostica está ...

Una característica especial del síndrome de Dravet es que muchas crisis pueden desencadenarse ... Effects of Cannabidiol in ...

y "es una niña feliz que disfruta de cualquier actividad", Sin embargo, es una niña única en Asturias: la única diagnosticada con Síndrome de Dravet, una enfermedad rara englobada en la ...

El oligonucleótido antisentido en investigación se dirige al gen SCN1A, que es la causa más frecuente del síndrome de Dravet, con el objetivo de aumentar la producción de proteínas en las ...

Study: Neonatal but not Juvenile Gene Therapy Reduces Seizures and Prolongs Lifespan in SCN1B-Dravet Syndrome Mice. Image Credit: Natali _ Mis/Shutterstock.com Developmental and epileptic ...

Biogen and Stoke Therapeutics have signed a partnership agreement to co-develop and sell Stoke’s experimental treatment for Dravet syndrome, a severe form of epilepsy, outside the U.S., the comp ...

Biogen and Stoke Therapeutics have agreed to collaborate on Stoke's proposed zorevunersen treatment for the severe genetic epilepsy Dravet syndrome in a deal potentially worth hundreds of millions ...

Biogen has entered a collaboration with Stoke Therapeutics to develop and and commercialise zorevunersen to treat Dravet syndrome in all territories outside Canada, Mexico and the US. Dravet ...

Existing treatments for Dravet include Jazz Pharmaceuticals’ Epidiolex and UCB’s Fintepla, but none of the approved products address the underlying genetic cause of the syndrome. Similarly ...

Zorevunersen is an investigational antisense oligonucleotide (ASO) that targets the SCN1A gene, the underlying cause of most cases of Dravet syndrome. Stoke recently announced plans to initiate a ...